Lilly antibody drug fails in a COVID-19 study; others go on


The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

©2020 GPlusMedia Inc.

Login to comment

It doesn’t work! Yes but give us permission to flog a useless drug anyway! Just looking to make money off the sick and fearful.

-1 ( +1 / -2 )

By this point is quite obvious that the immune response that is effective against COVID-19 much more complicated than just antibody mediated neutralization. The efforts are understandable because everybody wants to do their part in ending the pandemic, but having really humble advantages do not justify the costs and risks from using antibodies.

Trying serum was natural, then only hyperimmune serum because low antibody levels were not being effective, and now purified antibodies only, without having a clear advantage. Scientifically is useful to see how the infection is not interrupted, but medically it may be already time to give up on this.

3 ( +4 / -1 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites